David Hollenback
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 4
- Sphingolipid Metabolism and Signaling 2
- Peroxisome Proliferator-Activated Receptors 2
- Oncology 4
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Jack W. Singer (9 shared papers)Lynn Bonham (9 shared papers)Thayer White (4 shared papers)Archana Vijayakumar (3 shared papers)David G. Breckenridge (6 shared papers)John Tulinsky (3 shared papers)Bruno Marchand (2 shared papers)Jamie Bates (4 shared papers)
- Journals
- Journal of Hepatology (6 papers)Clinical Cancer Research (2 papers)Expert Opinion on Therapeutic Targets (2 papers)Journal of Lipid Research (1 paper)Metabolism (1 paper)
- Partner nations
- United StatesAustriaSouth Africa
In The Last Decade
David Hollenback
19 papers receiving 415 citations
Peers
Comparison fields: 5 of 55
- Biochemistry 128
- Hepatology 63
- Cancer Research 55
- Epidemiology 123
- Cell Biology 60
Countries citing papers authored by David Hollenback
This map shows the geographic impact of David Hollenback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hollenback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hollenback more than expected).
Fields of papers citing papers by David Hollenback
This network shows the impact of papers produced by David Hollenback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hollenback. The network helps show where David Hollenback may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hollenback, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 160 | |
| 2 | 2005 | 50 | |
| 3 | Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. | 2003 | 49 |
| 4 | 2003 | 39 | |
| 5 | 2005 | 30 | |
| 6 | 2006 | 23 | |
| 7 | 2006 | 18 | |
| 8 | 2023 | 17 | |
| 9 | 2022 | 9 | |
| 10 | 2005 | 9 | |
| 11 | 2008 | 8 | |
| 12 | 1998 | 3 | |
| 13 | 2017 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2005 | 1 | |
| 18 | 2003 | 1 | |
| 19 | 2006 | 1 | |
| 20 | 2020 | 0 |
About David Hollenback
David Hollenback is a scholar working on Molecular Biology, Oncology, Epidemiology, Biochemistry and Surgery, having authored 21 papers that have together received 428 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Lipid metabolism and biosynthesis (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Cancer, Lipids, and Metabolism (2 papers), Sphingolipid Metabolism and Signaling (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Biochemistry (128 citations), Hepatology (63 citations), Cancer Research (55 citations), Epidemiology (123 citations) and Cell Biology (60 citations). David Hollenback has collaborated with scholars based in United States, Austria and South Africa. Frequent co-authors include Jack W. Singer, Lynn Bonham, Thayer White, Archana Vijayakumar, David G. Breckenridge, John Tulinsky, Bruno Marchand, Jamie Bates, Saritha Kusam and Michael Coon. Their work appears in journals such as Journal of Hepatology, Clinical Cancer Research, Expert Opinion on Therapeutic Targets, Journal of Lipid Research and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.